Gujarat-based GSP Crop Science Limited has announced a price band of ₹304 to ₹320 per equity share, each with a face value of ₹10, for its maiden Initial Public Offering (IPO).
The Company’s Initial Public Offering (IPO) will open for subscription on Monday, March 16, 2026, and close on Wednesday, March 18, 2026.
Investors can bid for a minimum of 46 equity shares and in multiples of 46 equity shares thereafter. As of the date of the offer, the company has 39,018,750 outstanding equity shares, each with a face value of ₹10.
The IPO comprises a fresh issue aggregating up to ₹240 crore and an Offer for Sale (OFS) of up to 5,000,000 equity shares by the promoters — Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, and Kappa Trust.
The proceeds from the fresh issue to the extent of Rs 170 crore will be used for repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by the company, and general corporate purposes.
GSP Crop Science is a research-driven agrochemical company, specializing in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India, with over 40 years of experience in the agrochemical industry.
It provides its customers with crop protection solutions designed to support farmers in maximizing productivity and achieving optimal agricultural output. As of September 30, 2025 the company has received 524 registrations across formulations and technical for agrochemicals manufactured by it.
The company reported revenue from operations of ₹844.2 crore for the six months ended September 30, 2025, with a net profit of ₹81 crore during the same period.
For FY25, revenue from operations stood at ₹1,287.38 crore, compared to ₹1,203.3 crore in FY23. Net profit for FY25 was ₹81.4 crore, significantly higher than ₹17.5 crore recorded in FY23.
The issue is being managed by Equirus Capital Private Limited and Motilal Oswal Investment Advisors Limited as the book-running lead managers, while MUFG Intime India Private Limited is acting as the registrar to the offer.
The IPO is being conducted through the book-building process, with not more than 50% of the net offer reserved for qualified institutional buyers (QIBs), while non-institutional investors will receive up to 15%, and retail individual investors up to 35% of the net offer, in accordance with regulatory guidelines.
